PRP in OA knee - update, current confusions and future options.
Positive results have been uniformly observed by various researchers for platelet-rich plasma (PRP) in early osteoarthritis (OA) knee in the past few years. PRP has clearly demonstrated its supremacy in comparison to hyaluronic acid (HA) and placebo in various clinical trials and is undoubtedly the best option available for symptomatic treatment in early OA. The release of growth factors from PRP occurs immediately and lasts for around three weeks and the clinical effect tends to wane down by the end of the year. Prolonged and sustained release of growth factors from platelets could possibly help in much better biological healing and sustained clinical effects. PRP in combination with biocompatible carriers could be one way of achieving this. Gelatin hydrogel PRP and chitosan PRP seem to be promising based on early in vitro studies and animal studies. PRP in combination with hyaluronic acid also seems to be additive. This article intends to discuss the present status of the PRP, confusions surrounding its use, upcoming trends and ideas for improvising PRP for use early OA knees based on available evidence.
Department of Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Mandeep S
MS
Dhillon
Department of Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Sandeep
S
Patel
Department of Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Rakesh
R
John